Researchers discover novel mechanism of tumor adaptation to hypoxia in glioma patients, which could lead to methods of improving patient prognosis.
This article reviews the current status of research describing the prevalence and significance of fatigue among high-grade glioma patients.
Better prognosis for glioblastoma patients with seizures has raised questions about the anti-tumor properties of antiepileptic drugs. This article reviews the potential mechanisms associated with this.
Researchers have shown that a well-established optics technique termed second and third harmonic generation imaging could reveal the exact position of brain tumors in almost real time.
This article reviews the links between malignant brain tumors and fatigue, examinging evidence of effects on survival, pathophysiology and treatment interventions for fatigue.
This article evaluates the potential role of personalized medicine and the challenges facing it’s use in the treatment of CNS tumors.
Liposomes coupled with MRI contrast agents could enable safe and efficient passing of therapeutic agents through the blood-brain barrier.
Preclinical experiments have highlighted Nicotinamide phosphoribosyltransferase inhibitors as a potential treatment for IDH1 mutant gliomas.
New study suggests targeting brain cancer treatment to cells surrounding a tumor in order to prevent spread.
A new method for classifying low and intermediate grade gliomas has recently been reported in the in the New England Journal of Medicine. This new approach could lead to improvements in diagnosis, treatment and potentially patient outcomes.